MBOT Key Statistics, Chart & Performance
The current stock price of MBOT is 2.275 USD. In the past month the price increased by 21.11%. In the past year, price increased by 141%.
MBOT Latest News, Press Relases and Analysis
MBOT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.71 | 223.09B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.77 | 197.69B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.23 | 136.55B | ||
| SYK | STRYKER CORP | 26.86 | 135.27B | ||
| BDX | BECTON DICKINSON AND CO | 13.92 | 57.28B | ||
| IDXX | IDEXX LABORATORIES INC | 56.41 | 56.80B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.54 | 48.53B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.41 | 38.50B | ||
| RMD | RESMED INC | 25.44 | 36.76B | ||
| DXCM | DEXCOM INC | 35.52 | 25.77B | ||
| PODD | INSULET CORP | 64.13 | 20.62B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.45 | 18.35B |
Related stock screener links
About MBOT
Company Profile
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Company Info
MICROBOT MEDICAL INC
175 Derby St Bld 27
Hingham MASSACHUSETTS 02043 US
CEO: Harel Gadot
Employees: 20
Phone: 17818753605
MICROBOT MEDICAL INC / MBOT FAQ
What does MICROBOT MEDICAL INC do?
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
What is the stock price of MICROBOT MEDICAL INC today?
The current stock price of MBOT is 2.275 USD. The price decreased by -5.6% in the last trading session.
Does MICROBOT MEDICAL INC pay dividends?
MBOT does not pay a dividend.
What is the ChartMill technical and fundamental rating of MBOT stock?
MBOT has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of MICROBOT MEDICAL INC (MBOT)?
MICROBOT MEDICAL INC (MBOT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.46).
Can you provide the upcoming earnings date for MICROBOT MEDICAL INC?
MICROBOT MEDICAL INC (MBOT) will report earnings on 2026-03-23, after the market close.
MBOT Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to MBOT. When comparing the yearly performance of all stocks, MBOT is one of the better performing stocks in the market, outperforming 93.16% of all stocks.
MBOT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MBOT. No worries on liquidiy or solvency for MBOT as it has an excellent financial health rating, but there are worries on the profitability.
MBOT Financial Highlights
Over the last trailing twelve months MBOT reported a non-GAAP Earnings per Share(EPS) of -0.46. The EPS increased by 35.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.99% | ||
| ROE | -16.71% | ||
| Debt/Equity | 0 |
MBOT Forecast & Estimates
7 analysts have analysed MBOT and the average price target is 8.93 USD. This implies a price increase of 292.31% is expected in the next year compared to the current price of 2.275.